|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided (used) in operations: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Allowance for doubtful accounts | |||||
| Gain on disposal of assets | |||||
| Unrealized foreign exchange gain (loss) | |||||
| Changes in non-cash working capital: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Prepaid expenses and deposits | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Development of software | |||||
| Purchase of property, equipment, and intangibles | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Common stock repurchased for cancellation | |||||
| Repurchase of stock options for retirement | |||||
| Net cash used in financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplementary disclosure: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
Loading...